Literature DB >> 8550814

Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells.

W S Walker1, J Gatewood, E Olivas, D Askew, C E Havenith.   

Abstract

We developed a panel of non-virus transformed cell lines derived from individual microglial precursors residing in the brains of normal mice. These colony stimulating factor-1-dependent cell lines are B7-1+ (CD80), Mac-1+, Mac-2+, Mac-3+, CD45+, MHC class I+, colony stimulating factor-1 receptor+, and they ingest antibody-coated particles. However, the cell lines differ in their expression of B7-2 (CD86), F4/80, Ly-6C and MHC class II molecules. They also differ in their ability to constitutively process and present antigens to naive CD4+ and CD8+ T cells, memory CD4+ and CD8+, and in the manner by which interferon gamma modulates their antigen-presenting activities. These cell lines should be valuable as models for studies on the immunobiology of the microglia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550814     DOI: 10.1016/0165-5728(95)00146-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Modeling CNS microglia: the quest to identify predictive models.

Authors:  Monica J Carson; Janelle Crane; Alison X Xie
Journal:  Drug Discov Today Dis Models       Date:  2008

2.  Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures.

Authors:  Kenneth Hensley; Alexandar Christov; Shekhar Kamat; X Cai Zhang; Kenneth W Jackson; Stephen Snow; Jan Post
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

3.  TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.

Authors:  Matthew McMillin; Gabriel Frampton; Richard Tobin; Giuseppina Dusio; Jenny Smith; Hope Shin; Karen Newell-Rogers; Stephanie Grant; Sharon DeMorrow
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

4.  Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors.

Authors:  Meng Xu; Hai-Yun Wu; Hao Liu; Nian Gong; Yi-Rui Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2017-02-16       Impact factor: 8.739

5.  Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus.

Authors:  J K Olson; A M Girvin; S D Miller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  RIG-I is required for VSV-induced cytokine production by murine glia and acts in combination with DAI to initiate responses to HSV-1.

Authors:  Emma K Crill; Samantha R Furr-Rogers; Ian Marriott
Journal:  Glia       Date:  2015-07-03       Impact factor: 7.452

7.  The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1.

Authors:  Sally L Ellis; Vanessa Gysbers; Peter M Manders; Wen Li; Markus J Hofer; Marcus Müller; Iain L Campbell
Journal:  J Immunol       Date:  2010-06-28       Impact factor: 5.422

8.  Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.

Authors:  Gladson Muthian; John J Bright
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

9.  Thrombin-induced regulation of CD95(Fas) expression in the N9 microglial cell line: evidence for involvement of proteinase-activated receptor(1) and extracellular signal-regulated kinase 1/2.

Authors:  Jonathan R Weinstein; Matthew Zhang; Mansur Kutlubaev; Richard Lee; Caroline Bishop; Henrik Andersen; Uwe-Karsten Hanisch; Thomas Möller
Journal:  Neurochem Res       Date:  2008-08-07       Impact factor: 3.996

10.  Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury.

Authors:  Mousumi Ghosh; Daniela Garcia-Castillo; Vladimir Aguirre; Roozbeh Golshani; Coleen M Atkins; Helen M Bramlett; W Dalton Dietrich; Damien D Pearse
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.